NCT03783351View on ClinicalTrials.gov

Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)

NAActive, not recruitingINTERVENTIONAL
Enrollment

4,009

Participants

Timeline

Start Date

May 27, 2019

Primary Completion Date

April 30, 2025

Study Completion Date

August 31, 2025

Conditions
Angina, StableAcute Coronary SyndromeDrug-Eluting StentsGenotype
Interventions
GENETIC

CYP2C19 genotype testing

CYP2C19 genotype testing will be conducted in a designated central laboratory.

Trial Locations (9)

100000

Beijing Chaoyang Hospital, Beijing

100029

Beijing Anzhen Hospital, Beijing

100032

Peking Union Medical College Hospital, Beijing

100037

Fuwai Hospital Chinese Academy of Medical Sciences, Beijing

100050

Beijing Friendship Hospital, Beijing

100730

Beijing Tong Ren Hospital, Beijing

101199

Beijing LuHe Hospital, Beijing

102218

Beijing Tsinghua Changgung Hospital, Beijing

Unknown

China-Japan Friendship Hospital, Beijing

All Listed Sponsors
lead

Beijing Anzhen Hospital

OTHER